← All Cellectar Biosciences, INC filings

Cellectar Biosciences, INC Form 4 insider transactions

NASDAQ
CLRB
Cellectar Biosciences, INC
Form 4: Cellectar Biosciences Director Stefan Loren Acquires Stock Options Following Stockholder Approval
Director Stefan Loren acquired stock options in Cellectar Biosciences after stockholder approval of the amended 2021 Stock Incentive Plan.
NASDAQ
CLRB
Cellectar Biosciences, INC
Form 4: Cellectar Biosciences Director Douglas J. Swirsky Acquires 90,000 Stock Options
Director Douglas J. Swirsky acquired 90,000 stock options in Cellectar Biosciences following stockholder approval of the amended 2021 Stock Incentive Plan.
NASDAQ
CLRB
Cellectar Biosciences, INC
Form 4: Cellectar Biosciences Director John Neis Granted Stock Options Following Shareholder Approval
Director John Neis receives stock options after Cellectar Biosciences' shareholders approve the amended 2021 Stock Incentive Plan.
NASDAQ
CLRB
Cellectar Biosciences, INC
Form 4: Cellectar Biosciences Director Acquires Stock Options Following Stockholder Approval
Frederick Driscoll, a director of Cellectar Biosciences, acquired stock options for 60,000 shares after stockholder approval of the amended 2021 Stock Incentive Plan.
NASDAQ
CLRB
Cellectar Biosciences, INC
Form 4: Cellectar Biosciences Director Asher Chanan-Khan Granted Stock Options Following Stockholder Approval
Director Asher Chanan-Khan received stock options for 60,000 shares of Cellectar Biosciences after stockholder approval of the amended 2021 Stock Incentive Plan.